Form 4 for TRAW Traws Pharma, Inc.
Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-18 · accession 0001179110-21-010259 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-19 | 2021-11-18 | TRAW | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | X - OptEx | $3.00 | +5,000 | 17.5K | +40% | +$15.0K |
| D | 2021-11-19 | 2021-11-18 | TRAW | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | X - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-18 | X | A | 5,000 | $3.00 | 17,514 | D | — | — | (F1) Includes 9,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. |
| 2 | Derivative | Warrant (right to purchase) | 2021-11-18 | X | D | 5,000 | $0.00 | 0 | D | $3.00 · 2019-11-25 to 2024-11-25 | 5,000 Common Stock | (F2) The warrants were acquired in the November 2019 public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. |